Medicines Co. (MDCO) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($0.76), $0.02 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $7.77 million versus the consensus estimate of $7.99 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Sezzle Inc. (SEZL) Reports Q3 EPS of $1.37 ; Offers Guidance
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
